Back to Search Start Over

RAS Pathway Mutations Are Associated with Progression after Hypomethylating Agent Therapy in Chronic Myelomonocytic Leukemia

Details

ISSN :
15280020 and 00064971
Volume :
140
Database :
OpenAIRE
Journal :
Blood
Accession number :
edsair.doi...........87fa90c4dd14b6a29143085e3f71d947
Full Text :
https://doi.org/10.1182/blood-2022-170069